share_log

Ardelyx | 8-K: Current report

Ardelyx | 8-K: Current report

Ardelyx | 8-K:重大事件
美股sec公告 ·  05/23 17:02
Moomoo AI 已提取核心信息
Ardelyx, Inc., a biopharmaceutical company traded on the Nasdaq Global Market under the symbol ARDX, has filed a Form 8-K with the U.S. Securities and Exchange Commission on May 22, 2024. The report announces the resignation of Susan Rodriguez from her position as Chief Commercial Officer of Ardelyx. The decision was mutually agreed upon by both parties. To ensure a smooth transition, Ms. Rodriguez will continue to serve in an advisory capacity to the company until the end of 2024. The company's headquarters are located in Waltham, Massachusetts, and it is incorporated in the state of Delaware. No other material events, financial statements, or exhibits were disclosed in the filing.
Ardelyx, Inc., a biopharmaceutical company traded on the Nasdaq Global Market under the symbol ARDX, has filed a Form 8-K with the U.S. Securities and Exchange Commission on May 22, 2024. The report announces the resignation of Susan Rodriguez from her position as Chief Commercial Officer of Ardelyx. The decision was mutually agreed upon by both parties. To ensure a smooth transition, Ms. Rodriguez will continue to serve in an advisory capacity to the company until the end of 2024. The company's headquarters are located in Waltham, Massachusetts, and it is incorporated in the state of Delaware. No other material events, financial statements, or exhibits were disclosed in the filing.
Ardelyx, Inc. 是一家在纳斯达克全球市场上市的生物制药公司,股票代码为ARDX,该公司已于2024年5月22日向美国证券交易委员会提交了8-K表格。该报告宣布苏珊·罗德里格斯辞去Ardelyx首席商务官的职务。该决定是双方共同商定的。为确保平稳过渡,罗德里格斯女士将继续以顾问身份在公司任职至2024年底。该公司的总部位于马萨诸塞州沃尔瑟姆,并在特拉华州注册成立。申报中没有披露其他重大事件、财务报表或证物。
Ardelyx, Inc. 是一家在纳斯达克全球市场上市的生物制药公司,股票代码为ARDX,该公司已于2024年5月22日向美国证券交易委员会提交了8-K表格。该报告宣布苏珊·罗德里格斯辞去Ardelyx首席商务官的职务。该决定是双方共同商定的。为确保平稳过渡,罗德里格斯女士将继续以顾问身份在公司任职至2024年底。该公司的总部位于马萨诸塞州沃尔瑟姆,并在特拉华州注册成立。申报中没有披露其他重大事件、财务报表或证物。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息